Lord, Abbett & Co’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-57,273	Closed	-$7.11M	–	899
2018 Q2	$7.11M	Buy	57,273 +3,717	+7%	+$434K	0.02%	679
2018 Q1	$5.97M	Sell	53,556 -142,534	-73%	-$17M	0.02%	698
2017 Q4	$23.4M	Sell	196,090 -17,791	-8%	-$2.17M	0.07%	429
2017 Q3	$30M	Buy	+213,881	New	+$29.1M	0.09%	365
2016 Q1	–	Sell	-229,415	Closed	-$43.8M	–	970
2015 Q4	$43.8M	Buy	229,415 +160,287	+232%	+$28M	0.13%	241
2015 Q3	$10.8M	Sell	69,128 -23,051	-25%	-$4.2M	0.03%	571
2015 Q2	$16.7M	Sell	92,179 -40,150	-30%	-$6.93M	0.04%	535
2015 Q1	$22.9M	Sell	132,329 -15,830	-11%	-$2.87M	0.06%	450
2014 Q4	$27.4M	Buy	148,159 +87,210	+143%	+$16.2M	0.07%	396
2014 Q3	$10.1M	Sell	60,949 -3,443	-5%	-$565K	0.03%	599
2014 Q2	$10.1M	Buy	+64,392	New	+$10.2M	0.02%	640
2014 Q1	–	Sell	-51,668	Closed	-$6.88M	–	1097
2013 Q4	$6.88M	Buy	+51,668	New	+$6.2M	0.02%	755